Insulin-like growth factor-1 for the prevention or treatment of retinopathy of prematurity. (PubMed, Cochrane Database Syst Rev) - Apr 15, 2026 - "The available data are of very low certainty, and so we are not able to draw conclusions about the effects of treatment with IGF-1 in preterm infants for preventing or treating ROP, or about its effects on risk of serious adverse events, mortality, or hypoglycemia in this population."
Clinical • Journal • Review • Hypoglycemia • Retinal Disorders • Retinopathy of Prematurity • IGF1 • IL2RG
|
|
David W Sink; Graham E Quinn; James I Hagadorn; Jane Cracknell; Jennifer M Trzaski; Katherine W Herbst; Marissa G Iverson
|